(Q37844532)

24 August 2017

Impact of fibromyalgia severity on health economic costs: results from a European cross-sectional study (English)

1 reference

24 August 2017

0 references

Andreas Winkelmann

1

1 reference

24 August 2017

Serge Perrot

2

1 reference

24 August 2017

Caroline Schaefer

3

1 reference

24 August 2017

Kellie Ryan

4

1 reference

24 August 2017

Arthi Chandran

5

1 reference

24 August 2017

Alesia Sadosky

6

1 reference

24 August 2017

Gergana Zlateva

7

1 reference

24 August 2017

1 March 2011

1 reference

Applied Health Economics and Health Policy

24 August 2017

1 reference

24 August 2017

9

1 reference

24 August 2017

2

1 reference

24 August 2017

125-136

1 reference

https://scigraph.springernature.com/pub.10.2165/11535250-000000000-00000

24 August 2017

0 references

cites work

The prevalence and characteristics of fibromyalgia in the general population.

1 reference

https://api.crossref.org/works/10.2165%2F11535250-000000000-00000

Sleep disturbances in fibromyalgia syndrome: relationship to pain and depression

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11535250-000000000-00000

Employees with fibromyalgia: medical comorbidity, healthcare costs, and work loss

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11535250-000000000-00000

Pathogenesis of fibromyalgia - a review

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11535250-000000000-00000

The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11535250-000000000-00000

EULAR evidence-based recommendations for the management of fibromyalgia syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11535250-000000000-00000

Large differences in cost of illness and wellbeing between patients with fibromyalgia, chronic low back pain, or ankylosing spondylitis

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11535250-000000000-00000

The impact of a diagnosis of fibromyalgia on health care resource use by primary care patients in the UK: an observational study based on clinical practice.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11535250-000000000-00000

Societal and patient burden of fibromyalgia syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11535250-000000000-00000

Health economic consequences related to the diagnosis of fibromyalgia syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11535250-000000000-00000

Characteristics of patients with fibromyalgia in France and Germany.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11535250-000000000-00000

Minimal clinically important difference in the fibromyalgia impact questionnaire

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11535250-000000000-00000

Identification of cut-points for mild, moderate and severe pain due to diabetic peripheral neuropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11535250-000000000-00000

Treating patients with fibromyalgia in primary care settings under routine medical practice: a claim database cost and burden of illness study

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11535250-000000000-00000

10.2165/11535250-000000000-00000

21 January 2018

Identifiers

DOI

1 reference

Dimensions Publication ID

24 August 2017

0 references

1 reference